The Epidemiologic study of Parkinson’s Disease in Taiwan

碩士 === 高雄醫學大學 === 醫學研究所碩士班 === 95 === In Taiwan’s aging society, the proportion of the elderly with Parkinson’s disease (PD) is rising and this brings about some effects on the quality of our daily life. We used Panel Claims Data of National Health Insurance Beneficiaries from 1996 to 2004 to calcul...

Full description

Bibliographic Details
Main Authors: Ching-Ing Tseng, 曾菁英
Other Authors: Chun-Yuh Yang
Format: Others
Language:zh-TW
Published: 2007
Online Access:http://ndltd.ncl.edu.tw/handle/13708055589830485582
Description
Summary:碩士 === 高雄醫學大學 === 醫學研究所碩士班 === 95 === In Taiwan’s aging society, the proportion of the elderly with Parkinson’s disease (PD) is rising and this brings about some effects on the quality of our daily life. We used Panel Claims Data of National Health Insurance Beneficiaries from 1996 to 2004 to calculate the level of PD in Taiwan. A person was considered as PD if the database claim contained the ICD-9-CM diagnosis code 332.0, or A code A221. Then, prevalence and incidence rates were calculated and we conducted retrospective methods to analyze risk factors between people with and without PD. The prevalence rate of Parkinson’s disease was 340 per 100,000 population in Taiwan. After a follow-up period of 8 years, 791 subjects with incident PD were identified. The prevalence and incidence of PD increased with age, with prevalence rates for PD increasing from 130 per 100,000 population in subjects 50 to 59 years of age, to 726.67 per 100,000 population for those aged 80 or older. Incidence rates for PD increased from 131.03 per 100,000 person-years in subjects 50 to 59 years of age, to 979.31 per 100,000 person-years for those 80 or older. Ageing, diabetes, stroke, and psychosis were significantly more frequent in PD than controls, but hyperlipidemia was significantly less frequent in PD than controls. The prevalence rate in Taiwan was higher than in Japan and China. The incidence rate in Taiwan was lower than in Italy, Spain, and the Netherlands. Further research could focus on the idiopathy of Parkinson’s disease.